Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 7

Clinical outcome of B2/C type isolated proximal LAD disease treated with drug-eluting stents

İlaç kaplı stentlerle tedavi edilen B2/C tipi izole proksimal LAD hastalığının klinik sonuçları

Pages
648–649
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KALAY, N., PEKDEMİR, H., ÇİÇEK, D., MÜDERRİSOĞLU, H. (2022). Clinical outcome of B2/C type isolated proximal LAD disease treated with drug-eluting stents. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 7, 648–649. https://ajindex.com/articles/648449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kimura BJ, Russo RJ, Bhargava V, McDaniel MB, Peterson KL, Demaria AN. Atheroma morphology and distribution in proximal left anterior descending coronary artery: in vivo observations. J Am Coll Cardiol 1996; 27: 825-31. [CrossRef] 2. Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 2005; 130: 512-9. [CrossRef] 3. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, et al. SIRIUS Investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004; 110: 3773-80. [CrossRef] 4. Halkin A, Stone GW. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials. J Interv Cardiol 2004; 17: 271-82. [CrossRef] 5. Krone RJ, Shaw RE, Klein LW, Block PC, Anderson HV, Weintraub WS, et al. ACC-National Cardiovascular Data Registry. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current “stent era” of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol 2003; 92; 389-94. [CrossRef] 6. Regar E, Serruys PW. The Ravel trial. Zero percent restenosis: A cardiologists dream comes true! Rev Esp Cardiol 2002; 55: 459-62. [CrossRef] 7. Popma JJ, Leon MB, Moses JW, Holmes DR Jr, Cox N, Fitzpatrick M, et al. SIRIUS investigators. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation 2004; 110: 3773-80. [CrossRef] 8. Moreno R. Drug-eluting stents and other anti-restenosis devices. Rev Esp Cardiol 2005; 58: 842-62. [CrossRef] 9. Kim JW, Lim DS, Sun K, Shim WJ, Rho YM. Stenting or MIDCAB using mini-sternotomy for revascularization of proximal left anterior descending artery? Int J Cardiol 2005; 99: 437-41. 10. Sawhney N, Moses JW, Leon MB, Kuntz RE, Popma JJ, Bachinsky W, et al. Treatment of left anterior descending coronary disease with sirolimus-eluting stents. Circulation 2004; 110: 374-9. [CrossRef] 11. Dangas G, Ellis SG, Shlofmitz R, Katz S, Fish D, Martin S, et al. for the TAXUS-IV Investigators: Outcomes of paclitaxel-eluting